← Contracts
PT
Ajuste direto para aquisição de RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA] e RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA]
ID 13560462
· Portal BASE
Price
Base Price
€597,008
.00
Effective Price
€3,233
.00
-99.5%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Porto, Póvoa de Varzim
- Bidder Count
- —
Winner
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Dates
- Publication
- 23 Feb 2026
- Celebration
- 22 Jan 2026
Contracting Entity
Unidade Local de Saúde da Póvoa de Varzim/Vila do Conde, EPE
NIF 508741823
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
- Authority
- 1558
- Supplier
- 253
- Number of Awards
- 6
- Rule
- A1 repeat direct award: 6 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 23 Feb 2026
- Signing Date
- 22 Jan 2026
- Days Late
- 32
- Rule
- A2/A3 late publication: 32 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 597008.0
- Total effective price
- 3233.0
- Ratio
- 0.0054
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0054 outside [0.5, 1.5]
Detected 2026-03-06